通过全科医生和药剂师的合作,信息化和加强临床医生的参与,优化初级保健中的多药房管理:IMPPP集群随机试验
Rupert A Payne1, Peter S Blair2, Barbara Caddick3
1Exeter Collaboration for Academic Primary Care, University of Exeter, Exeter, UK.
The lancet. Healthy longevity
|October 19, 2025
概括
复杂的干预措施并没有减少多药患者可能不适当的处方. 这挑战了当前医疗保健策略的药物管理和患者安全.
科学领域:
- 初级护理研究初级护理研究
- 临床药房 临床药房 临床药房
- 医疗服务研究 医疗服务研究
背景情况:
- 多药学对患者安全和有效利用医疗保健资源构成重大挑战.
- 管理多药店需要平衡治疗效益与风险,以临床和患者优先事项为指导.
- 支持当前多药店管理指南的证据有限.
研究的目的:
- 评估一项旨在减少可能不适当处方的复杂干预措施,用于治疗多药的初级保健患者.
- 这项名为"改善初级保健中多药患者的药物使用 (IMPPP) "的研究调查了该干预措施的有效性.
主要方法:
- 一个务实的,集群随机试验,涉及英国的一般做法.
- 参与者是成年人 (18+),至少服用五种常规药物,有潜在不适当处方指标.
- 该干预涉及以患者为中心的药物审查,在信息,培训,反和激励的支持下,与通常的护理相比.
主要成果:
- 在干预和常规护理组之间26周的潜在不适当处方指标没有显著差异 (两者的平均值为2.3).
- 这项研究包括了1950名患者,随机分配到37家全科医院.
- 没有报告与干预相关的死亡或意外入院.
结论:
- 测试的复杂药物优化干预措施在减少对多药房患者可能不适当的处方方面无效.
- 研究结果表明,需要重新评估当前的医疗保健政策和对数字解决方案,临床药房和结构化药物审查的投资.
- 该研究的结果与医疗保健管理的主流政策方向形成鲜明对比.
相关概念视频
Drug Dosing: Geriatric Patients
222
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
222
Primary Healthcare Services
1.9K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.9K
Drug Therapy
239
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
239
Nursing Clinical Information System
1.2K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.2K
Methods of Documentation II: POMR
1.4K
The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
1.4K
Dosage Regimens: Partial Pharmacokinetic Parameters
148
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
148


